Amazon to Stop Selling Seven Eyedrops After F.D.A. Warningnews2023-11-15T16:16:27+00:00November 15th, 2023|The New York Times|
Zepbound, el nuevo medicamento aprobado por la FDA para perder pesonews2023-11-13T10:01:53+00:00November 13th, 2023|The New York Times|
Weight Loss Drug Wegovy Can Cut Heart Attack Risk for Some, Study Showsnews2023-11-12T05:20:43+00:00November 12th, 2023|The New York Times|
Gonorrhea Is Becoming Drug Resistant. Scientists Just Found a Solution.news2023-11-10T10:03:01+00:00November 10th, 2023|The New York Times|
‘Crisis vergonzosa’: la sífilis congénita repunta en EE. UU.news2023-11-10T08:00:23+00:00November 10th, 2023|The New York Times|
The Republican Alternatives to Trumpnews2023-11-09T18:28:53+00:00November 9th, 2023|The New York Times|
Sexual Dysfunction After Stopping SSRI Antidepressantsnews2023-11-09T10:00:24+00:00November 9th, 2023|The New York Times|
The Traffic Jam in Low Earth Orbitnews2023-11-09T06:02:37+00:00November 9th, 2023|The New York Times|
F.D.A. Approves New Obesity Drug Tirzepatide That Will Compete With Wegovynews2023-11-09T01:02:09+00:00November 9th, 2023|The New York Times|
FDA Approves Zepbound, A Drug Like Ozempic, for Weight Loss. Here’s What to Know.news2023-11-08T18:34:20+00:00November 8th, 2023|The New York Times|
